Naples, Italy

Ettore Novellino

This inventor holds 1 USPTO granted patent. Top assignee: Università Degli Studi Di Trento. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ettore Novellino. Retrieved from https://idiyas.com/inventor/ettore-novellino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ettore Novellino: Innovator in Aza-Tanshinone Derivatives

Introduction

Ettore Novellino is a notable inventor based in Naples, Italy. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on aza-tanshinone derivatives. His research focuses on developing new therapeutic agents that can be used in the treatment of various medical conditions.

Latest Patents

Ettore Novellino holds a patent for "Aza-tanshinone derivatives, process for their preparation and their use in therapy." This invention encompasses new aza-tanshinone derivatives, a method for their preparation, and their application in therapy, especially as anti-tumor agents and anti-inflammatories. The invention also includes pharmaceutical compositions containing these derivatives. He has 1 patent to his name.

Career Highlights

Ettore Novellino is affiliated with the University of Trento, where he contributes to research and development in the pharmaceutical sciences. His work has been instrumental in advancing the understanding of aza-tanshinone derivatives and their potential therapeutic applications.

Collaborations

Ettore has collaborated with notable colleagues, including Alessandro Provenzani and Vito Giuseppe D'Agostino. Their combined expertise has furthered research in the field and enhanced the impact of their findings.

Conclusion

Ettore Novellino's innovative work in the development of aza-tanshinone derivatives showcases his commitment to advancing medical therapies. His contributions are paving the way for new treatments that could significantly benefit patients in need.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…